MedTrace Logo

Acupuncture for Blunt Chest Trauma

NCT04318496 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2021-11-17

No results posted yet for this study

Summary

Introduction:

Chest blunt trauma accounts in up to 65% of polytrauma patients. In patients with 0-2 rib fracture, the treatment is relatively limited to oral pain killer and breathing exercise. The patients will suffer two weeks of severe pain accompanied with poor sleep and inability to preform simple daily live activities. In this double blind randomized control study, the investigators offer acupuncture as an additional treatment option.

Methods:

The study is a double blind randomized control trial. the study will include the press needle acupuncture (Acu) and placebo (Con) group. Both groups will receive one treatment, following the first visit to the clinic after chest trauma accident.

Conditions

  • Chest Trauma
  • Rib Fractures

Interventions

OTHER

Press Tack Acupuncture

PYONEX Φ0.20×0.6 mm made by Seirin Corporation

OTHER

Press Tack Placebo

PYONEX placebo sticker made by Seirin Corporation

Sponsors & Collaborators

  • China Medical University Hospital

    lead OTHER

Principal Investigators

  • Peiyu Kao, M.D. · China Medical University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-23
Primary Completion
2021-06-30
Completion
2021-06-30

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04318496 on ClinicalTrials.gov